Carregant...
Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms. A variety of factors are responsible for the resistant to treatment, including individual variations in patients and somatic cell genetic di...
Guardat en:
| Publicat a: | J Immunol Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925139/ https://ncbi.nlm.nih.gov/pubmed/29850620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1982423 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|